Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and disrupting the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely. A small amount of the wart remover should then be applied using the provided applicator, ensuring that each wart is sufficiently covered.

This application should be allowed to dry, and the procedure may be repeated once or twice daily. Treatment can continue until the wart is removed, with a maximum duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

• In patients with diabetes or poor blood circulation, unless under the advice and supervision of a healthcare professional.

• On genital warts and warts located on the face.

• On moles, birthmarks, and warts with hair growing from them.

• On mucous membranes.

• On skin that is irritated, infected, or reddened.

These contraindications are established to prevent potential adverse effects and complications associated with the use of this product in these specific conditions.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame. It is essential to cap the bottle tightly and store it at room temperature, away from heat sources.

This product should not be used by individuals who are diabetic or have poor blood circulation unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. It is contraindicated for use on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. Additionally, it should not be applied to mucous membranes or on skin that is irritated, infected, or reddened.

When using this product, it is crucial to avoid contact with the eyes. In the event of contact, the eyes should be flushed with water for at least 15 minutes. Users should also take care to avoid inhaling vapors.

If discomfort persists, it is advised to discontinue use and consult a healthcare professional.

This product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients should be aware that this product is intended for external use only. It is contraindicated for individuals who are diabetic or have poor blood circulation, unless used under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. The product should not be applied to genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, it should not be used on mucous membranes or on skin that is irritated, infected, or reddened.

During use, patients should take care to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors from the product.

Patients are advised to discontinue use and consult a doctor if discomfort persists. It is important to keep this product out of reach of children. In the case of accidental ingestion, medical assistance should be sought immediately, or contact a Poison Control Center for guidance.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (liquid wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should be advised against the use of this product if they have diabetes or poor blood circulation, unless under the guidance and supervision of a healthcare professional. The product is intended for external use only and is flammable; therefore, it should be kept away from fire or flame. It is important to store the product at room temperature and away from heat sources.

While using this product, pregnant patients should avoid contact with the eyes. In the event of contact, the eyes should be flushed with water for 15 minutes. Additionally, inhalation of vapors should be avoided. If discomfort persists, patients are advised to discontinue use and consult a healthcare provider.

As with all medications, this product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center should be made.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that this product is not recommended for use in individuals with diabetes or poor blood circulation unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. It is also important to instruct patients not to use the product on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, patients should be cautioned against applying the product on mucous membranes or on skin that is irritated, infected, or reddened.

Healthcare providers should emphasize that if discomfort persists after using the product, patients should stop use and consult their doctor. Patients should also be advised to avoid contact with their eyes while using the product; if contact occurs, they should flush their eyes with water for 15 minutes. Furthermore, patients should be warned to avoid inhaling vapors from the product to ensure their safety during use.

Storage and Handling

The product is supplied in a tightly capped bottle. It is essential to store the bottle at room temperature, ensuring it is kept away from heat sources. The recommended storage temperature range is between 20° to 30°C (68° to 86°F). Additionally, it is crucial to keep the product away from fire or flame to ensure safety and integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)